ConductScience.org, home

Trial · NCT00809848

Results by group15

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Change From Baseline in Average Eye Intraocular Pressure (IOP)AGN-210669 Ophthalmic Solution, 0.075%Baseline - Hour 025.350Standard Deviation 2.8018Millimeters of Mercury (mmHg)
Change From Baseline in Average Eye Intraocular Pressure (IOP)AGN-210669 Ophthalmic Solution, 0.05%Baseline - Hour 025.318Standard Deviation 2.9377Millimeters of Mercury (mmHg)
Change From Baseline in Average Eye Intraocular Pressure (IOP)AGN-210669 Ophthalmic Solution, 0.025%Baseline - Hour 025.341Standard Deviation 2.6375Millimeters of Mercury (mmHg)
Change From Baseline in Average Eye Intraocular Pressure (IOP)Bimatoprost Ophthalmic Solution 0.03%Baseline - Hour 024.650Standard Deviation 2.0622Millimeters of Mercury (mmHg)
Change From Baseline in Average Eye Intraocular Pressure (IOP)AGN-210669 Vehicle Ophthalmic SolutionBaseline - Hour 025.507Standard Deviation 2.9004Millimeters of Mercury (mmHg)
Change From Baseline in Average Eye Intraocular Pressure (IOP)AGN-210669 Ophthalmic Solution, 0.075%Change from Baseline at Day 14 - Hour 0-5.807Standard Deviation 3.7007Millimeters of Mercury (mmHg)
Change From Baseline in Average Eye Intraocular Pressure (IOP)AGN-210669 Ophthalmic Solution, 0.05%Change from Baseline at Day 14 - Hour 0-5.197Standard Deviation 3.1947Millimeters of Mercury (mmHg)
Change From Baseline in Average Eye Intraocular Pressure (IOP)AGN-210669 Ophthalmic Solution, 0.025%Change from Baseline at Day 14 - Hour 0-4.068Standard Deviation 2.8520Millimeters of Mercury (mmHg)
Change From Baseline in Average Eye Intraocular Pressure (IOP)Bimatoprost Ophthalmic Solution 0.03%Change from Baseline at Day 14 - Hour 0-6.575Standard Deviation 3.2184Millimeters of Mercury (mmHg)
Change From Baseline in Average Eye Intraocular Pressure (IOP)AGN-210669 Vehicle Ophthalmic SolutionChange from Baseline at Day 14 - Hour 0-2.382Standard Deviation 2.9396Millimeters of Mercury (mmHg)
Percentage of Patients With ≥ 20% Reduction From Baseline in Diurnal IOPAGN 210669 Non-preserved Ophthalmic Solution, 0.075%62.9Percentage of Patients
Percentage of Patients With ≥ 20% Reduction From Baseline in Diurnal IOPAGN-210669 Ophthalmic Solution, 0.05%57.6Percentage of Patients
Percentage of Patients With ≥ 20% Reduction From Baseline in Diurnal IOPAGN-210669 Ophthalmic Solution, 0.025%30.3Percentage of Patients
Percentage of Patients With ≥ 20% Reduction From Baseline in Diurnal IOPBimatoprost Ophthalmic Solution 0.03%63.3Percentage of Patients
Percentage of Patients With ≥ 20% Reduction From Baseline in Diurnal IOPAGN-210669 Vehicle Ophthalmic Solution2.8Percentage of Patients

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00809848/results